OMRF is a nonprofit biomedical research institute with over 50 labs and 450 staff studying cancer, heart disease, autoimmune disorders, and diseases of aging. Their breakthroughs have led to three FDA-approved drugs, including the first targeted therapy for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder. Their critical research is helping people live longer, healthier lives, and they have garnered worldwide media attention. OMRF's researchers are pushing the boundaries of biomedical science to win the war against human disease.